EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/16/2026
Back to search
Official data from USPTO
SYNTHESIS-TO-CLINIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYNTHESIS-TO-CLINIC
ST13
US500000079336901Class
42
Filing
79336901
Registration
7445088
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/03/2026
Trademark type
Word
Nice classes
42
Filing date
11/05/2021
Registration date
07/16/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/16/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Quotient Sciences Ltd
Representatives
Jonathan P. Soifer Sandberg Phoenix
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research services relating to the pharmaceuticalbiotechnology and nutraceutical industry
Publications
History of USPTO decisions and trademark events.
42 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/16/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/16/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/16/2026
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/21/2024
FIMP
FINAL DISPOSITION PROCESSED
12/21/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/16/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/30/2024
PUBO
PUBLISHED FOR OPPOSITION
04/30/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/29/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/28/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/27/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/27/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/30/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/30/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/28/2023
GNFR
FINAL REFUSAL E-MAILED
08/28/2023
CNFR
FINAL REFUSAL WRITTEN
08/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/14/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/13/2023
DOCK
ASSIGNED TO EXAMINER
03/01/2023
RFNT
REFUSAL PROCESSED BY IB
01/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/13/2022
RFRR
REFUSAL PROCESSED BY MPU
12/13/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/30/2022
CNRT
NON-FINAL ACTION WRITTEN
09/29/2022
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
09/28/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/24/2022
CNRT
NON-FINAL ACTION WRITTEN
08/23/2022
DOCK
ASSIGNED TO EXAMINER
08/17/2022
MAFR
APPLICATION FILING RECEIPT MAILED
04/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/31/2022
Continuous trademark protection
Get notified about every new filing that threatens SYNTHESIS-TO-CLINIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.